Skip to content

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05649072
Enrollment
1000
Registered
2022-12-13
Start date
2022-11-18
Completion date
2027-02-02
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Ovarian Cancer

Brief summary

Identifying women at risk for hereditary cancer potentiates prevention, early detection or personalised treatment against cancer. We using mobile mammography units will provide genetic sceening and testing services to underserved women coming for thier mammograms to these units.

Detailed description

Objectives: 1. To identify underserved women at risk for hereditary breast and colorectal cancers and would be eligible for standard of care genetic counseling and testing using national screening guidelines. 2. To provide education to providers and patients regarding hereditary cancers using previously IRB approved educational material and short video.

Interventions

Participants will be asked to collect a saliva sample for hereditary cancer and genetic testing

BEHAVIORALScreening Form

Participant will be answering demographic details

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
Community Outreach and Engagement Fund for Underserved Texans
CollaboratorUNKNOWN

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Any woman scheduled at Project VALET mammography screening mobile units will be eligible for this study.

Design outcomes

Primary

MeasureTime frame
To identify underserved women at risk for hereditary breast and colorectal cancers eligible for standard-of-care genetic counseling using national screening guidelines.through study completion; an average of 1 year.

Countries

United States

Contacts

CONTACTArun Banu, MD
barun@mdanderson.org(713) 792-2817
PRINCIPAL_INVESTIGATORArun Banu, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026